Ingo Elfering

CIO, Advisor, Digital Transformation in Healthcare, 
Entrepreneur, Creator

With over 20 years of experience in the global pharmaceutical and healthcare sector, Ingo is a passionate and visionary leader in IT and digital transformation. As the Group CIO at Fresenius Group, he is responsible for modernizing IT and shaping new digital solutions and services with state-of-the-art technology.

Ingo has a strong record of accomplishment of delivering innovative and impactful IT solutions across various functions and platforms, such as commercial, supply chain, R&D, and digital farming. Ingo leverages technological enthusiasm, deep IT expertise, and strong industry knowledge to connect the dots and create value for the business and the patients. He is also an intrapreneur and a former founder and CEO of a successful software and consulting company in the digital health IT space.

Ingo believes that diversity, curiosity, and collaboration are essential to drive innovation and change within the company. He fosters a culture of openness, transparency, and trust among my team and stakeholders, and encourages them to contribute their ideas and challenge the status quo. Outside of work, he enjoys travel and photography.

Public links to some of my projects can be found on my LinkedIn profile

CIO Expertise

Multiple times Global CIO in various Companies ranging from smaller BioPharma to large scale global Pharma, MedTech, Generics to Agriculture and Hospitals.

Strategic Advisor

Trusted advisors to C-Suite and Boards on Technology, Innovation, CyperSecurity and Digital Transformation. 

Digital Transformation in Healthcare

From Product Innovation to Digital Services, Technologies to Business Models, to use of AI/ML/Data.

Entrepreneurial Mindset

Founder of a Startup, including successful pivot and exit. Able to connect the dots, strong business focus and driving new Change.


Ingo enjoys photography and cooking as main hobbies. He likes to post photos at 500px


Some Examples here:

©Copyright. All rights reserved.

We need your consent to load the translations

We use a third-party service to translate the website content that may collect data about your activity. Please review the details and accept the service to view the translations.